What is the Optimal Technique for Hydrodistention?

Status Enrolling by invitation

Clinical Trial Summary

This research study is being done to learn what is the best way to perform hydrodistention. Eligible participants will be enrolled and have follow-up for three months after surgery. The study team hypothesizes that changes in hydrodistention technique, including pressure, number of distention, and duration of distention, leads to no or minimal changes in symptom improvement for patients with Interstitial cystitis/bladder pain syndrome (IC/BPS).

Clinical Trial Description

Hydrodistention is a procedure designed to treat bladder and pelvic symptoms in patients with interstitial cystitis. A camera is placed inside the bladder and the bladder is filled with fluid. This procedure "resets" the signals between the bladder and brain, in order to reduce the symptoms of interstitial cystitis (such as bladder pain, urinary urgency/frequency/dysuria, incontinence, incomplete emptying, etc). However, it is still unknown the best way to perform hydrodistention. Doctors do not know how much fluid to put in the bladder, how long to keep the fluid in the bladder, and how many times to fill the bladder. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05456308
Study type	Interventional
Source	University of Michigan
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	July 1, 2022
Completion date	October 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04313972` - IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone	Phase 4
Completed	`NCT03282318` - A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis	Phase 2
Completed	`NCT03463499` - The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients	N/A
Completed	`NCT02898220` - Trans-MAPP II Study of Urologic Chronic Pelvin Pain
Terminated	`NCT02591199` - Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome	Phase 2
Completed	`NCT02247557` - Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis	Phase 2
Active, not recruiting	`NCT01731470` - Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)	N/A
Completed	`NCT01197261` - OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)	Phase 2
Completed	`NCT00971568` - Urinary Biomarkers Characteristic to Interstitial Cystitis	N/A
Completed	`NCT00527917` - A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.	Phase 2
Completed	`NCT00150488` - URACYST® For the Treatment of GAG Deficient Interstitial Cystitis	N/A
Recruiting	`NCT00094874` - Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms	Phase 3
Terminated	`NCT00086684` - Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis	Phase 4
Recruiting	`NCT04845217` - Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome	Phase 1/Phase 2
Completed	`NCT04401176` - Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome	Phase 2
Recruiting	`NCT05147779` - Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis	Phase 1
Suspended	`NCT04450316` - Low-dose Naltrexone for Bladder Pain Syndrome	Phase 2
Completed	`NCT04010513` - Hypnosis for Bladder Pain Syndrome	N/A
Completed	`NCT05179460` - A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy
Completed	`NCT02232282` - Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial	N/A